Stay updated on CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial

Sign up to get notified when there's something new on the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Added a Locations section listing new sites in Arizona, California, Connecticut, Florida, Maryland, Nebraska, New York, Ohio, Pennsylvania, and Tennessee. Removed the individual state location sections and the HHS Vulnerability Disclosure link; updated the revision from v3.3.2 to v3.3.3.
    Difference
    0.9%
    Check dated 2025-12-23T08:43:18.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:15:13.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    A new revision label v3.3.1 was added and the previous v3.2.0 label was removed.
    Difference
    0.0%
    Check dated 2025-11-24T14:32:45.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The page's funding notice about government operations has been removed; the study details, eligibility criteria, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:50:10.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    No significant changes to core study information (design, eligibility criteria, endpoints, or results) are evident between the screenshots; the differences appear limited to minor UI/formatting updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:18:14.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    Core content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-05T10:34:19.000Z thumbnail image

Stay in the know with updates to CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page.